Dr. ID: 40302

Sarah Jane Pauline Minner

graph of relations

Publications

  1. 2017
  2. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

    Jacobsen, F., Kraft, J., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Sauter, G., Izbicki, J. R., Clauditz, T. S., Luebke, A. M., Hinsch, A., Wilczak, W., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Melling, N., 09.2017, In: NEOPLASIA. 19, 9, p. 707-715 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

    Urbanucci, A., Barfeld, S. J., Kytölä, V., Itkonen, H. M., Coleman, I. M., Vodák, D., Sjöblom, L., Sheng, X., Tolonen, T., Minner, S., Burdelski, C., Kivinummi, K. K., Kohvakka, A., Kregel, S., Takhar, M., Alshalalfa, M., Davicioni, E., Erho, N., Lloyd, P., Karnes, R. J., Ross, A. E., Schaeffer, E. M., Vander Griend, D. J., Knapp, S., Corey, E., Feng, F. Y., Nelson, P. S., Saatcioglu, F., Knudsen, K. E., Tammela, T. L. J., Sauter, G., Schlomm, T., Nykter, M., Visakorpi, T. & Mills, I. G., 06.06.2017, In: CELL REP. 19, 10, p. 2045-2059 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy

    Soave, A., Riethdorf, S., Dahlem, R., Minner, S., Weisbach, L., Engel, O., Fisch, M., Pantel, K. & Rink, M., 06.2017, In: BJU INT. 119, 6, p. 854-861 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer

    Heumann, A., Kaya, Ö., Burdelski, C., Hube-Magg, C., Kluth, M., Lang, D. S., Simon, R., Beyer, B., Thederan, I., Sauter, G., Izbicki, J. R., Luebke, A. M., Hinsch, A., Jacobsen, F., Wittmer, C., Büscheck, F., Höflmayer, D., Minner, S., Tsourlakis, M. C., Schlomm, T. & Wilczak, W., 17.05.2017, In: SCI REP-UK. 7, 1, p. 2056

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer

    Burdelski, C., Borcherding, L., Kluth, M., Hube-Magg, C., Melling, N., Simon, R., Möller-Koop, C., Weigand, P., Minner, S., Haese, A., Michl, H. U., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Izbicki, J. R., Sauter, G., Krech, T., Büscheck, F., Clauditz, T., Schlomm, T. & Wilczak, W., 09.05.2017, In: ONCOTARGET. 8, 19, p. 31494-31508 15 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers

    Burdelski, C., Fitzner, M., Hube-Magg, C., Kluth, M., Heumann, A., Simon, R., Krech, T., Clauditz, T., Büscheck, F., Steurer, S., Wittmer, C., Hinsch, A., Luebke, A. M., Jacobsen, F., Minner, S., Tsourlakis, M. C., Beyer, B., Steuber, T., Thederan, I., Sauter, G., Izbicki, J., Schlomm, T. & Wilczak, W., 04.2017, In: NEOPLASIA. 19, 4, p. 279-287 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. βIII-tubulin overexpression is linked to agressive tumor features and genetic instability in urinary bladder cancer

    Hinsch, A., Chaker, A., Burdelski, C., Koop, C., Tsourlakis, M. C., Steurer, S., Rink, M., Eichenauer, T. S., Wilczak, W., Wittmer, C., Fisch, M., Simon, R., Sauter, G., Büschek, F., Clauditz, T., Minner, S. & Jacobsen, F., 03.2017, In: HUM PATHOL. 61, p. 210-220

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

    Melling, N., Rashed, M., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Möller-Koop, C., Steurer, S., Sauter, G., Jacobsen, F., Büscheck, F., Wittmer, C., Clauditz, T., Krech, T., Tsourlakis, M. C., Minner, S., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Wilczak, W., 29.01.2017, In: INT J MOL SCI. 18, 2, p. 286

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 10.01.2017, In: ONCOTARGET. 8, 2, p. 3761

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  11. Deletion of 8p is an independent prognostic parameter in prostate cancer

    Kluth, M., Amschler, N. N., Galal, R., Möller-Koop, C., Barrow, P., Tsourlakis, M. C., Jacobsen, F., Hinsch, A., Wittmer, C., Steurer, S., Krech, T., Büscheck, F., Clauditz, T. S., Beyer, B., Wilczak, W., Graefen, M., Huland, H., Minner, S., Schlomm, T., Sauter, G. & Simon, R., 03.01.2017, In: ONCOTARGET. 8, 1, p. 379-392 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

    Wilczak, W., Rashed, S., Hube-Magg, C., Kluth, M., Simon, R., Büscheck, F., Clauditz, T. S., Grupp, K., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Sauter, G., Izbicki, J. R., Huland, H., Schlomm, T., Steurer, S., Krech, T. & Lebok, P., 01.2017, In: CARCINOGENESIS. 38, 1, p. 19-27

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2016
  14. Deletion of 18q is a strong and independent prognostic feature in prostate cancer

    Kluth, M., Graunke, M., Koop, C., Hube-Magg, C., Minner, S., Michl, U., Graefen, M., Huland, H., Pompe, R., Jacobsen, F., Hinsch, A., Wittmer, C., Lebok, P., Steurer, S., Büscheck, F., Clauditz, T., Wilczak, W., Sauter, G., Schlomm, T. & Simon, R., 27.12.2016, In: ONCOTARGET. 7, 52, p. 86339-86349 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. p16 upregulation is linked to poor prognosis in ERG negative prostate cancer

    Burdelski, C., Dieckmann, T., Heumann, A., Hube-Magg, C., Kluth, M., Beyer, B., Steuber, T., Pompe, R., Graefen, M., Simon, R., Minner, S., Tsourlakis, M. C., Koop, C., Izbicki, J., Sauter, G., Krech, T., Schlomm, T., Wilczak, W. & Lebok, P., 09.2016, In: TUMOR BIOL. 37, 9, p. 12655-12663 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients

    Tsourlakis, M-C., Stender, A., Quaas, A., Kluth, M., Wittmer, C., Haese, A., Graefen, M., Steurer, S., Simon, R., Korbel, J., Weischenfeldt, J., Huland, H., Sauter, G., Schlomm, T. & Minner, S., 17.08.2016, In: BMC CANCER. 16, p. 641

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer

    Lennartz, M., Minner, S., Brasch, S., Wittmann, H., Paterna, L., Angermeier, K., Öztürk, E., Shihada, R., Ruge, M., Kluth, M., Koop, C., Wilczak, W., Krech, T., Lebok, P., Wittmer, C., Heinzer, H., Steuber, T., Adam, M., Huland, H., Graefen, M., Haese, A., Simon, R., Sauter, G. & Schlomm, T., 01.06.2016, In: CLIN CANCER RES. 22, 11, p. 2802-11 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens

    Sauter, G., Steurer, S., Clauditz, T. S., Krech, T., Wittmer, C., Lutz, F., Lennartz, M., Janssen, T., Hakimi, N., Simon, R., von Petersdorff-Campen, M., Jacobsen, F., Loga, K., Wilczak, W., Minner, S., Tsourlakis, M. C., Chirico, V., Haese, A., Heinzer, H., Beyer, B., Graefen, M., Michl, U., Salomon, G., Steuber, T., Budäus, L. H., Hekeler, E., Malsy-Mink, J., Kutzera, S., Fraune, C., Göbel, C., Huland, H. & Schlomm, T., 01.04.2016, In: EUR UROL. 69, 4, p. 592-8

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

    Burdelski, C., Kleinhans, S., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Marx, A., Sauter, G., Wittmer, C., Huland, H., Simon, R., Schlomm, T. & Steurer, S., 01.03.2016, In: INT J CANCER. 138, 5, p. 1199-206

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

    Pust, A., Kylies, D., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Grob, T., Graefen, M., Salomon, G., Tsourlakis, M. C., Izbicki, J., Wittmer, C., Huland, H., Simon, R., Wilczak, W., Sauter, G., Steurer, S., Krech, T., Schlomm, T. & Melling, N., 02.2016, In: HUM PATHOL. 48, p. 102-10 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

    Melling, N., Taskin, B., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Grob, T., Graefen, M., Heinzer, H., Tsourlakis, M. C., Izbicki, J., Wittmer, C., Huland, H., Simon, R., Wilczak, W., Sauter, G., Steurer, S., Schlomm, T. & Krech, T., 02.2016, In: PROSTATE. 76, 3, p. 259-72 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer

    Kluth, M., Meyer, D., Krohn, A., Freudenthaler, F., Bauer, M., Salomon, G., Heinzer, H., Michl, U., Steurer, S., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 26.01.2016, In: ONCOTARGET. 7, 4, p. 3897-904

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. 2015
  24. Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer

    Kluth, M., Runte, F., Barow, P., Omari, J., Abdelaziz, Z. M., Paustian, L., Steurer, S., Christina Tsourlakis, M., Fisch, M., Graefen, M., Tennstedt, P., Huland, H., Michl, U., Minner, S., Sauter, G., Simon, R., Adam, M. & Schlomm, T., 15.11.2015, In: INT J CANCER. 137, 10, p. 2354-63 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

    Melling, N., Thomsen, E., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Wilczak, W., Huland, H., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 11.2015, In: CARCINOGENESIS. 36, 11, p. 1333-40 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma

    Quaas, A., Rahvar, A-H., Burdelski, C., Koop, C., Eichelberg, C., Rink, M., Dahlem, R., Schlomm, T., Tsourlakis, M. C., Simon, R., Minner, S., Sauter, G. & Steurer, S., 10.2015, In: WORLD J UROL. 33, 10, p. 1561-1569

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

    Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G. & Schlomm, T., 29.09.2015, In: ONCOTARGET. 6, 29, p. 27966-79 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

    Grupp, K., Roettger, L., Kluth, M., Hube-Magg, C., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Sauter, G., Wilczak, W., Huland, H., Schlomm, T., Steurer, S. & Krech, T., 09.2015, In: Oncology reports. 34, 3, p. 1211-20 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

    Burdelski, C., Reiswich, V., Hube-Magg, C., Kluth, M., Minner, S., Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wittmer, C., Huland, H., Simon, R., Schlomm, T., Sauter, G. & Steurer, S., 01.08.2015, In: CLIN CANCER RES. 21, 15, p. 3471-9 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation

    Itkonen, H. M., Engedal, N., Babaie, E., Luhr, M., Guldvik, I. J., Minner, S., Hohloch, J., Tsourlakis, M. C., Schlomm, T. & Mills, I. G., 01.07.2015, In: ONCOGENE. 34, 28, p. 3744-50

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibility

    Schiffmann, J., Wenzel, P., Salomon, G., Budäus, L., Schlomm, T., Minner, S., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Sauter, G., Beyer, B., Boehm, K., Tilki, D., Michl, U., Huland, H., Graefen, M. & Karakiewicz, P. I., 07.2015, In: UROL ONCOL-SEMIN ORI. 33, 7, p. 329.e13-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. PSMA expression is highly homogenous in primary prostate cancer

    Tsourlakis, M. C., Klein, F., Kluth, M., Quaas, A., Graefen, M., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 07.2015, In: APPL IMMUNOHISTO M M. 23, 6, p. 449-55 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

    Soave, A., John, L-M., Dahlem, R., Minner, S., Engel, O., Schmidt, S., Kluth, L. A., Fisch, M. & Rink, M., 07.2015, In: UROLOGY. 86, 1, p. 92-8 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

    Kluth, M., Galal, R., Krohn, A., Weischenfeldt, J., Tsourlakis, M. C., Paustian, L., Ahrary, R., Ahmed, M., Scherzai, S., Meyer, A., Sirma, H., Korbel, J., Sauter, G., Schlomm, T., Simon, R. & Minner, S., 01.04.2015, In: INT J ONCOL. 46, 4, p. 1637-42 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

    Burdelski, C., Barreau, Y., Simon, R., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Sauter, G., Wittmer, C., Steurer, S., Adam, M., Huland, H., Schlomm, T., Tsourlakis, M. C. & Quaas, A., 01.04.2015, In: HUM PATHOL. 46, 4, p. 514-23 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

    Zabalza, C. V., Adam, M., Burdelski, C., Wilczak, W., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Koop, C., Hube-Magg, C., Graefen, M., Heinzer, H., Minner, S., Simon, R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 23.03.2015, In: ONCOTARGET. 6, 14, p. 12822-12834

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

    Burdelski, C., Ruge, O. M., Melling, N., Koop, C., Simon, R., Steurer, S., Sauter, G., Kluth, M., Hube-Magg, C., Minner, S., Wittmer, C., Wilczak, W., Hinsch, A., Lebok, P., Izbicki, J. R., Heinzer, H., Graefen, M., Huland, H., Schlomm, T. & Krech, T., 18.03.2015, In: EXP MOL PATHOL. 98, 3, p. 419-426 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    Burdelski, C., Strauss, C., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Krech, T., Sauter, G., Wilczak, W., Simon, R., Schlomm, T. & Steurer, S., 25.02.2015, In: ONCOTARGET.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?

    Soave, A., Schmidt, S., Dahlem, R., Minner, S., Engel, O., Kluth, L. A., John, L-M., Hansen, J., Schmid, M., Sauter, G., Shariat, S. F., Fisch, M. & Rink, M., 01.01.2015, In: UROL ONCOL-SEMIN ORI. 33, 1, p. 21.e1-9

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

    Melling, N., Harutyunyan, L., Hube-Magg, C., Kluth, M., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Steurer, S., Izbicki, J., Sauter, G., Wilczak, W., Schlomm, T. & Krech, T., 2015, In: PLOS ONE. 10, 7, p. e0134614

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

    Burdelski, C., Bujupi, E., Tsourlakis, M. C., Hube-Magg, C., Kluth, M., Melling, N., Lebok, P., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Wilczak, W., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: PLOS ONE. 10, 6, p. e0128525

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    Burdelski, C., Menan, D., Tsourlakis, M. C., Kluth, M., Hube-Magg, C., Melling, N., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Simon, R., Schlomm, T., Steurer, S. & Krech, T., 2015, In: BMC CANCER. 15, p. 538

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

    Tsourlakis, M. C., Khosrawi, P., Weigand, P., Kluth, M., Hube-Magg, C., Minner, S., Koop, C., Graefen, M., Heinzer, H., Wittmer, C., Sauter, G., Krech, T., Wilczak, W., Huland, H., Simon, R., Schlomm, T. & Steurer, S., 2015, In: INT J MOL SCI. 16, 4, p. 8591-606 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. 2014
  45. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

    Burandt, E., Bari Noubar, T., Lebeau, A., Minner, S., Burdelski, C., Jänicke, F., Müller, V., Terracciano, L., Simon, R., Sauter, G., Wilczak, W. & Lebok, P., 01.12.2014, In: ONCOL REP. 32, 6, p. 2628-34 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarrays

    Steurer, S., Singer, J. M., Rink, M., Chun, F., Dahlem, R., Simon, R., Burandt, E., Stahl, P., Terracciano, L., Schlomm, T., Wagner, W., Höppner, W., Omidi, M., Kraus, O., Kwiatkowski, M., Doh, O., Fisch, M., Soave, A., Sauter, G., Wurlitzer, M., Schlüter, H. & Minner, S., 01.11.2014, In: UROL ONCOL-SEMIN ORI. 32, 8, p. 1225-33 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

    Grupp, K., Boumesli, R., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 15.09.2014, In: INT J CANCER. 135, 6, p. 1399-1407

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer

    Brocks, D., Assenov, Y., Minner, S., Bogatyrova, O., Simon, R., Koop, C., Oakes, C., Zucknick, M., Lipka, D. B., Weischenfeldt, J., Feuerbach, L., Cowper-Sal Lari, R., Lupien, M., Brors, B., Korbel, J., Schlomm, T., Tanay, A., Sauter, G., Gerhäuser, C., Plass, C. & ICGC Early Onset Prostate Cancer Project, 07.08.2014, In: CELL REP. 8, 3, p. 798-806 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. TMPRSS2-ERG Fusions Are Strongly Linked to Young Patient Age in Low-grade Prostate Cancer

    Steurer, S., Mayer, P. S., Adam, M., Krohn, A., Koop, C., Ospina-Klinck, D., Tehrani, A. A., Simon, R., Tennstedt, P., Graefen, M., Wittmer, C., Brors, B., Plass, C., Korbel, J., Weischenfeldt, J., Sauter, G., Huland, H., Tsourlakis, M. C., Minner, S. & Schlomm, T., 08.07.2014, In: EUR UROL. 66, 6, p. 978-981

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer

    Grupp, K., Ospina-Klinck, D., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Simon, R., Sauter, G., Izbicki, J. R., Graefen, M., Huland, H., Steurer, S., Schlomm, T., Minner, S. & Quaas, A., 01.07.2014, In: PROSTATE. 74, 10, p. 1012-22 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)

    Clauditz, T. S., von Rheinbaben, K., Lebok, P., Minner, S., Tachezy, M., Borgmann, K., Knecht, R., Sauter, G., Wilczak, W., Blessmann, M. & Münscher, A., 27.06.2014, In: PATHOL RES PRACT. 210, 10, p. 649-655

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Patterns of ALK expression in different human cancer types

    Tennstedt, P., Strobel, G., Bölch, C., Grob, T., Minner, S., Masser, S. & Simon, R., 01.06.2014, In: J CLIN PATHOL. 67, 6, p. 477-81 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype

    Steurer, S., Seddiqi, A. S., Singer, J. M., Bahar, A. S., Eichelberg, C., Rink, M., Dahlem, R., Huland, H., Sauter, G., Simon, R., Minner, S., Burandt, E., Stahl, P. R., Schlomm, T., Wurlitzer, M. & Schlüter, H., 01.05.2014, In: ANTICANCER RES. 34, 5, p. 2255-61 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review